Difference between revisions of "Alpha synuclein"
m |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:AlphaSynuclein.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 30: | Line 30: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | VTAVA'' | + | | VTAVA''QK''TVEGA |
FVKKD''Q''LGKNE | FVKKD''Q''LGKNE | ||
| Line 39: | Line 39: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/ | + | | [http://gibk21.bse.kyutech.ac.jp/netasa/asaview/tmp/120866ext.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/netasa/asaview/tmp/120866ext.asa.asa.out ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 50: | Line 51: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:21, 10 March 2015
| Alpha synuclein | |
|---|---|
| |
| Substrate peptide name | Alpha synuclein |
| Synonyms | Non-A beta component of AD amyloid
Non-A4 component of amyloid precursor |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol |
| Swissprot ID | P37840 |
| Reactive glutamines | Q79, Q99 |
| Reactive lysines | K80 |
| Substrate sequence | VTAVAQKTVEGA
FVKKDQLGKNE |
| Structure | 1XQ8 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:12576551 |
| Notes | |
